Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
The Relevance of REMAP-ILD for Ibero-American Countries: A Randomized Embedded Multifactorial Adaptive Platform (REMAP) Trial in the Field of Interstitial Lung Diseases (ILDs)
Leticia Kawano-Dourado; Maria Molina-Molina; Jacobo Sellares; Juan I. Enghelmayer;
Arch Bronconeumol. 2024;60:463-5
Peripheral Immune Cell Profiling Reveals Distinct Immune Hallmarks in Progressive Pulmonary Fibrosis
Fernanda Hernandez-Gonzalez; Nuria Mendoza; Sandra Casas-Recasens; Tamara Cruz; Nuria Albacar; Gemma López-Saiz; Xavier Alsina-Restoy; Mauricio Rojas; Alvar Agusti; Jacobo Sellarés; Rosa Faner;
Arch Bronconeumol. 2023;59:681-4
Highlights for the Clinical Practice in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis: From the ATS/ERS/ALAT/JRS 2022 Guideline
Vanesa Vicens-Zygmunt; Maria Molina-Molina; Ganesh Raghu;
Arch Bronconeumol. 2023;59:73-5